The TAXUS Libert Post Approval Study ( TL-PAS ) contributed patients treated with TAXUS Libert paclitaxel-eluting stent and prasugrel to the Dual Antiplatelet Therapy Study ( DAPT ) that compared @ and @ months thienopyridine plus aspirin therapy after drug-eluting stents .